Vickie L. Capps is a member of Silverback Therapeutics’ board of directors and the audit committee chair. In addition to Silverback, Ms. Capps is a member of the board of directors and the audit committee chair of each of NuVasive, Inc., a public medical device company (Nasdaq:NUVA), Otonomy, Inc., a public biopharmaceutical company (Nasdaq:OTIC), and Amedisys, Inc., a public home health and hospice company (Nasdaq:AMED). Ms. Capps is also a member of the boards of directors of OmniGuide, Inc., a private medical device company, and the San Diego State University Research Foundation. She also serves as a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare focused private equity firm. She previously served as a member of the boards of directors of several other public and private companies, most recently, Synthorx, Inc. (Nasdaq), prior to its sale to Sanofi in January 2020, and Enclara Pharmacia (private) prior to its sale to Humana in January 2020. Ms. Capps started her career as an accounting and audit professional with a Big 4 public accounting firm, and went on to serve as the chief financial officer of several public and private companies. Ms. Capps is a Certified Public Accountant and she received her Bachelor of Science degree in business administration and accounting from San Diego State University.